Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for VTIAF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 17.43M
March 31, 2026 17.43M
December 31, 2025 17.43M
September 30, 2025 17.43M
June 30, 2025 17.43M
March 31, 2025 17.43M
December 31, 2024 17.43M
September 30, 2024 17.43M
June 30, 2024 17.43M
March 31, 2024 17.43M
December 31, 2023 17.43M
September 30, 2023 15.83M
June 30, 2023 15.83M
March 31, 2023 15.83M
December 31, 2022 15.83M
September 30, 2022 15.83M
June 30, 2022 15.83M
March 31, 2022 15.83M
December 31, 2021 15.83M
September 30, 2021 4.098M
June 30, 2021 4.098M
March 31, 2021 4.098M
December 31, 2020 4.098M
September 30, 2020 4.098M
June 30, 2020 4.098M
Date Value
March 31, 2020 4.098M
December 31, 2019 4.098M
September 30, 2019 4.084M
June 30, 2019 4.084M
March 31, 2019 4.084M
December 31, 2018 4.084M
September 30, 2018 4.084M
June 30, 2018 4.084M
March 31, 2018 4.084M
December 31, 2017 4.084M
September 30, 2017 4.084M
June 30, 2017 3.360M
March 31, 2017 3.049M
December 31, 2016 3.049M
September 30, 2016 3.049M
June 30, 2016 3.049M
March 31, 2016 3.049M
December 31, 2015 3.049M
September 30, 2015 3.113M
June 30, 2015 3.113M
March 31, 2015 3.113M
December 31, 2014 3.113M
September 30, 2014 3.113M
June 30, 2014 3.113M
March 31, 2014 3.113M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Fresenius Medical Care AG 532.22M
Global Cord Blood Corp. --
Cryo-Cell International, Inc. 8.063M
Rhön-Klinikum AG 133.88M
Cordlife Group Ltd. 256.31M